Final results from the vedolizumab extended access program multinational study demonstrate long-term treatment persistence and safety

Silvio Danese, Milan Lukáš, Miroslava Volfová, Grażyna Rydzewska, Shashi Adsul, Dirk Lindner, Stephen Jones, Séverine Vermeire

Open source

DOI: 10.1177/17562848251406092
Published: 2026-02
Container: Therapeutic Advances in Gastroenterology
Publisher: SAGE Publications
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/17562848251406092,
  title = {Final results from the vedolizumab extended access program multinational study demonstrate long-term treatment persistence and safety},
  author = {Silvio Danese and Milan Lukáš and Miroslava Volfová and Grażyna Rydzewska and Shashi Adsul and Dirk Lindner and Stephen Jones and Séverine Vermeire},
  year = {2026},
  journal = {Therapeutic Advances in Gastroenterology},
  doi = {10.1177/17562848251406092},
  url = {https://doi.org/10.1177/17562848251406092}
}

RIS

TY  - JOUR
TI  - Final results from the vedolizumab extended access program multinational study demonstrate long-term treatment persistence and safety
AU  - Silvio Danese
AU  - Milan Lukáš
AU  - Miroslava Volfová
AU  - Grażyna Rydzewska
AU  - Shashi Adsul
AU  - Dirk Lindner
AU  - Stephen Jones
AU  - Séverine Vermeire
PY  - 2026
JO  - Therapeutic Advances in Gastroenterology
DO  - 10.1177/17562848251406092
UR  - https://doi.org/10.1177/17562848251406092
ER  -

APA

Danese, S., Lukáš, M., Volfová, M., Rydzewska, G., Adsul, S., Lindner, D., Jones, S., & Vermeire, S. (2026). Final results from the vedolizumab extended access program multinational study demonstrate long-term treatment persistence and safety. Therapeutic Advances in Gastroenterology. https://doi.org/10.1177/17562848251406092

Source records

crossref · retrieved 2026-09-25T10:31:35.103Z